Mar 03, 2022 / 01:45PM GMT
Operator
Good day, and thank you for standing by. Welcome to the Arbutus Biopharma Corporation Fourth Quarter and Year-end 2021 Financial Results and Corporate Update Conference Call. (Operator Instructions)
I would now like to hand the conference to your speaker today, Lisa Caperelli, Vice President of Investor Relations. Please go ahead.
Lisa M. Caperelli - Arbutus Biopharma Corporation - VP of IR
Thank you, Katherine. Good morning, everyone, and thank you for joining Arbutus' fourth quarter and year-end financial and business update call. Joining me today from the Arbutus executive team are Bill Collier, President and Chief Executive Officer; David Hastings, Chief Financial Officer; Dr. Gaston Picchio, Chief Development Officer; and Dr. Michael Sofia, Chief Scientific Officer. Bill will begin with a review of recent accomplishments and clinical developments, followed by Dave Hastings who will provide a review of the company's fourth quarter and year-end financial results.
After opening remarks, we will open the call up for Q&A. Gaston Picchio
Q4 2021 Arbutus Biopharma Corp Earnings Call Transcript
Mar 03, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers